Our analysis revealed increased plasma levels of DNAJC9, DNAJC17, and DNAJA4 in PLWH diagnosed with COVID-19, though these elevations were not statistically significant after FDR adjustment. This evidence concerns the gene DNAJA4 and COVID-19.